|本期目录/Table of Contents|

[1]沈 杰,马爱英,刘秋如,等.经皮微波凝固综合治疗转移性肝癌[J].医学研究与战创伤救治(原医学研究生学报),2008,10(01):19-21.
　SHEN Jie,MA Ai-ying,LIU Qiu-ru,et al.Percutaneous microwave coagulation comprehensive therapy for metastatic liver cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(01):19-21.
点击复制

经皮微波凝固综合治疗转移性肝癌()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第10卷
期数:
2008年01期
页码:
19-21
栏目:
出版日期:
2008-01-20

文章信息/Info

Title:
Percutaneous microwave coagulation comprehensive therapy for metastatic liver cancer
文章编号:
1672-271X(2008)01-0019-03
作者:
沈 杰; 马爱英; 刘秋如; 丁 威; 王亚进
解放军第455医院肿瘤科，上海 200052
Author(s):
SHEN Jie; MA Ai-ying; LIU Qiu-ru; DING Wei; WANG Ya-jin
Department of Oncology,the 455th Hospital of PLA,Shanghai 200052,China
关键词:
肝转移癌;  微波凝固;  化学栓塞; 无水酒精; 化疗
Keywords:
Liver metastases;  Microwave coagulation;  Chemoembolization;  Ethanol;  Systemic chemotherapy
分类号:
R735.7
DOI:
-
文献标志码:
A
摘要:
目的 观察经皮微波凝固(PMCT)为主综合治疗转移性肝癌的疗效。方法 对35例转移性肝癌，共96个目标病灶，先行肝动脉化疗栓 塞术(TACE)，然后在超声引导下行PMCT和经皮瘤内注射无水酒精(PEI)，1个月后再进行全身静脉化疗。结果 经综合治疗后，患者受益率(CR+PR+SD)为88.6%，血清肿瘤指标转阴率 为75.9%(22/29)，中位生存期为24.5个月，1年和2年生存率分别为91.4%、51.4%。结论 以PMCT为主联合TACE、PEI和全身化疗治疗转移性肝癌是一种安全、有效、合理的综合序贯 治疗模式。
Abstract:
Objective To study the efficacy of percutaneous microwave coagulation(PMCT) comprehensive therapy for metastatic liver cancer.Methods 96 nodules of metastatic liver cancer in 35 patients were treated with transcatheter hepatic arterial chemoembolization (TACE), and followed by ultrasound-guided PMCT and percutaneous alcohol injection(PEI), then chemotherapy after a month.Results When the comprehensive therapies finished, response rate of patients was 88.6%, the normalized rate of serum tumor maker was 75.9%, median survival time was 24.5 months, 1-year and 2-year survival rates were 91.4% and 51.4%, respectively.Conclusion The comprehensive therapy including PMCT,TACE,PEI and chemotherapy for metastatic liver cancer is a safe, effective and rational mode.

参考文献/References:

[1]Nakamura S,Suzuki S,Baba S.Resection of live metastases of colorectal carcinoma[J].World J Surg,1997,21(7):741-747.
[2]沈 杰，马爱英，王海洁，等.经皮微波凝固联合肝动脉化疗栓塞治疗少血供型肝癌[J].中国临床医学杂志，2007,14(2):188-190.
[3]董宝玮，梁 萍，于晓玲，等.超声引导微波凝固治疗原发性肝癌(附120例临床分析)[J].中华超声影像学杂志，1999,8(4):217-221.
[4]黄 韬，李 波，林浩铭，等.转移性肝癌的外科治疗(附208例报告)[J].中国普外基础与临床杂志，2005,12(3):294-295.
[5]郭伟剑，孙 磊，宋明志，等.转移性肝癌外放射肝动脉化疗栓塞综合治疗[J].浙江肿瘤，1998,4(2):92-94.
[6]南克俊，魏永长，李春丽，等. 肝动脉插管栓塞化疗治疗转移性肝癌59例[J].第四军医大学学报，2002,23(7):618.
[7]Safi F, Bittner R, Roscher R,et al. Reginoal chemotherapy for hepatic metastases of colorectal carcinoma(continuous intraarterial versus continuous intraarterial/intravenous therapy)-Results of a controlled clinical therapy[J].Cancer,1989,64(2):379.
[8]王雅杰.肿瘤分子靶向治疗进展[J].实用肿瘤杂志，2006,21(3):209-212.

相似文献/References:

[1]王 颖,高明春,徐永茂,等.化疗栓塞联合微波治疗巨块型肝癌的护理体会[J].医学研究与战创伤救治(原医学研究生学报),2013,15(04):407.[doi:10.3969/j.issn.1672-271X.2013.04.035]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2013-11-22